Hospital General Tlahuac Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2013
NCT01875393
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now